Back to search

Article

Biopharmaceutical Classification System (BCS)

2025-06-09

Abstract excerpt

A BCS-based biowaiver for generic drugs requires high drug solubility throughout the physiological pH range plus identical product quality and near-identical reference product content to meet recommendation standards outlined by the 2017 FDA Guidance. The International Council for Harmonization gave its authorization to these procedures during 2018. The FDA employs identical terms while discussing BCS-based biowai...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2ac1ad23-a25e-5be9-8c75-0f40a8d46e2f
DOI
10.20944/preprints202506.0622.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Biopharmaceutical Classification System (BCS)DOI 10.20944/preprints202506.0622.v1
Select a neighboring publication to make it the new centre.